Longterm experience of magnerot administration in patients with mitral valve prolapse
Автор: Martynov A.I., Akatova E.V.
Рубрика: Оригинальные статьи
Статья в выпуске: 1, 2011 года.
Within 15 years observation 31 patients with prolaps the mitral valve, regularly accepting magnerot, in a dose of 1500 mg a day during all period of observation by 3-month's courses 2 times a year was spent. Features of dynamics of a clinical picture, their interrelation with phenotypic expression of a dysplasia of a connecting tissue, changes of an electrocardiogram, a structure of the valves apparatus of heart, a condition of a vegetative homeostasis, change of level and a daily profile of arterial pressure, a tonus of sympathetic and parasympathetic departments of vegetative nervous system are taped. Against treatment according to the retrospective analysis significant improvement of clinic-tool indicators at all surveyed patients isn't. After regular application of magnesium salt orotate acids authentic improvement of quality of life at patients with prolepses the mitral valve is established.
Dysplasia of a connecting tissue, prolaps the mitral valve, quality of life, variability of a rhythm of heart, magnerot
Короткий адрес: https://readera.ru/14342684